The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; 14 of the 54 sources its claims cite were checked for support.
Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR
Open accessAbstract
The C-terminal region of the tumor suppressor protein p53 contains three domains, nuclear localization signal (NLS), tetramerization domain (TET), and C-terminal regulatory domain (CTD), which are essential for p53 function. Characterization of the structure and interactions of these domains within full-length p53 has been limited by the overall size and flexibility of the p53 tetramer. Using trans -intein splicing, we have generated full-length p53 constructs in which the C-terminal region is isotopically labeled with 15 N for NMR analysis, allowing us to obtain atomic-level information on the C-terminal domains in the context of the full-length protein. Resonances of NLS and CTD residues have narrow linewidths, showing that these regions are largely solvent-exposed and dynamically disordered, whereas resonances from the folded TET are broadened beyond detection. Two regions of the CTD, spanning residues 369–374 and 381–388 and with high lysine content, make dynamic and sequence-independent interactions with DNA in regions that flank the p53 recognition element. The population of DNA-bound states increases as the length of the flanking regions is extended up to approximately 20 base pairs on either side of the recognition element. Acetylation of K372, K373, and K382, using a construct of the transcriptional coactivator CBP containing the TAZ2 and acetyltransferase domains, inhibits interaction of the CTD with DNA. This work provides high-resolution insights into the behavior of the intrinsically disordered C-terminal regions of p53 within the full-length tetramer and the molecular basis by which the CTD mediates DNA binding and specificity.
Overview
CoChat Summary
TL;DR
Using trans-intein splicing and segmental ¹⁵N labeling, the authors obtained atomic-level NMR data on the disordered C-terminal regions of full-length tetrameric p53. They show that the CTD dynamically binds DNA flanking the p53 recognition element, and that acetylation of K372/K373/K382 impairs this interaction.
Key findings
- The NLS and CTD remain largely disordered and highly dynamic in full-length p53; TET-domain resonances (Y327–G356) are broadened beyond detection in the full-length tetramer but are visible in the isolated p53(304–393) peptide.
- The CTD contacts DNA outside the 20-bp p53 recognition element: residues 369–374 and 381–388 show substantial chemical shift changes with a 60-bp DNA (DNA-L) but only minor changes with the 20-bp DNA-S. These interactions increase as flanking DNA length increases and level off beyond ~20 bp (~70 Å) on either side of the recognition element.
- CTD–DNA binding is sequence independent: similar CTD chemical shift changes occur with ATG-repeat flanks, random flanks, and native p21 flanks.
- Acetylation by CBP(1079–1855) at K372, K373, and K382 (confirmed by Western blot) impairs but does not completely abrogate CTD binding to DNA; K305 also showed chemical shift changes suggesting acetylation.
Methods
- Full-length p53 constructs contained the quadruple M133L/V203A/N239Y/N268D superstabilizing mutations; segmental labeling used Npu DnaE trans-intein splicing to produce p53 labeled with ¹⁵N at residues 304–393 [¹⁵N(304–393)-p53].
- NMR experiments included ¹H-¹⁵N HSQC, TROSY-HSQC, and SOFAST-HMQC at 25°C in 20 mM Tris, pH 7.0, 150 mM NaCl, 2 mM DTT, 5% D₂O; protein concentrations ranged from 30–150 μM. Backbone assignments for p53(304–393) were deposited in the BMRB under accession 51613.
- DNA constructs ranged from 20–80 bp, with a central 20-bp p53 recognition element flanked by 0–30 bp of (ATG)n or other sequences; p53:DNA complexes used a 4:1 protomer:DNA ratio (1:1 tetramer:DNA). Acetylation used CBP(1079–1855) at a 100:1 p53:CBP molar ratio with 1 mM acetyl-CoA.
Limitations
- The paper states that TET-domain backbone amide resonances are broadened beyond detection in full-length p53, so the authors cannot comment on potential TET:DNA interactions.
- The paper notes that four non-native residues (CFNG) are inserted at the splice site between S303/T304, causing substantial chemical shift differences for residues adjacent to the splice site.
- Evident from the text: all structural and interaction data are from in vitro purified-protein NMR experiments under defined buffer conditions, so the cellular context and physiological consequences of the observed CTD–DNA and acetylation effects are not directly measured.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
5 Valid · 3 Not valid · 18 Not checked · 46 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Binding of the DBDs to non-specific DNA, but not to cognate recognition elements, is autoinhibited by dynamic intramolecular interactions between the N-terminal activation domain (NTAD) and the DNA binding surface (Figure 8A).41,72,73”
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Discussion > Role of disordered N- and C-terminal regions in p53 target site search
What the sources say
- Supportedcites [41] source
The Discussion section 'Interactions Between the NTAD and the DBD Regulate DNA Binding' states that in the presence of the NTAD the affinity for nonspecific DNA is reduced by more than fivefold while there is no observable effect on binding to a cognate p53 recognition element, and that 'inhibition of nonspecific DNA binding occurs through competition between the NTAD and the DNA duplex for the binding surface of the p53 DBD.' The NMR/PRE results (section 'Trans-Intein Splicing Facilitates NMR Studies of Tetrameric p53') characterize these as weak, transient (dynamic) intramolecular contacts dominated by AD2 on the DNA-binding surface, matching every element of the citing sentence, including the autoinhibitory framing. (LLM, conf=0.90)
- Disputedcites [72] sourceExperimental — accuracy not yet measured
The mechanistic half of the claim is in our copy: NMR (Results, 'TAD2 Interacts with the DNA Binding Site on the DBD', Fig. 8) shows TAD2/PRR interacting with the DNA binding surface of the DBD in a weak, dynamic way that is displaced by DNA binding, and the Discussion proposes autoinhibition by nucleic acid mimicry or electrostatic screening. But the claim's exclusion of cognate elements is contrary to what the paper reports: the Results (ITC, Fig. 5A) state the NT decreased DBD affinity for consensus DNA by 26-fold as well as 60-fold for scrambled DNA, and in vivo ChIP showed removal of TAD2/PRR increased binding to specific promoters 10-20-fold; the Discussion summarizes that the NT reduces affinity (~10-fold) while increasing specificity (~twofold), i.e. both classes of binding are autoinhibited, nonspecific more so. Additionally, the paper hedges the strictly intramolecular nature: the interaction is strengthened in dimers/tetramers, 'suggesting that intersubunit interaction is favored in the tetramer' (Results, 'Intersubunit Interaction Between the NT and DBD'). (LLM, conf=0.75)
Checked by a reasoning model — may be wrong.
- Supportedcites [73] source
The introduction (p. 1) states that the AD1/AD2 motifs undergo "transient and dynamic intramolecular interactions with the structured DBD" that "compete with DNA for binding to the DBD and inhibit binding of the p53 tetramer to nonspecific DNA sites but not to a specific p21 recognition element." The Discussion ("The Multivalent Intrinsically Disordered AD2-DBD Interaction...", and "Phosphorylation Enhances Dynamic Intramolecular Interactions...") reiterates that these electrostatic NTAD-DNA-binding-surface contacts reduce nonspecific 20-bp binding ~sixfold in nonphosphorylated p53, and the two-state C/O autoinhibition model (Fig. 6A) frames the same mechanism. Caveat: this paper's own new result is that T55 (and S46/T55) phosphorylation extends the inhibition to the cognate p21 and DINP1 elements, so the "but not to cognate recognition elements" restriction holds for nonphosphorylated p53, which is how the paper reports it (originally credited to its ref. 15, but relied on and extended here). (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“The observation that NTAD41, NLS, and CTD resonances are narrow in spectra of full-length p53 and are shifted only slightly from their chemical shifts in isolated peptides is inconsistent with an oligomerization model proposed on the basis of low-resolution (13.7 Å) cryo-electron microscopy data, in which the TET adopts a radically different structure compared to its isolated state and forms st”
- Also stated in: § The C-terminal domains in the context of full-length p53 · boosted
“Therefore, the sharp resonances of the NTAD, coupled with the extremely broad resonances of the TET, argues strongly against the NTAD:TET interactions proposed by Okorokov et al.37”
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Discussion > The C-terminal domains in the context of full-length p53
What the sources say
- Partly supportedcites [37] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
- Disputedcites [64] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § The C-terminal domains in the context of full-length p53 · boosted
Every source the paper cites for this claim was checked and supports it.
In the paper
“acetylation at K372/K373 is required for activation of lower affinity p53 promoters that regulate pro-apoptotic genes.31”
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Discussion > Role of disordered N- and C-terminal regions in p53 target site search
What the sources say
- Supportedcites [31] source
The Discussion ('Why so many acetylation sites?') states that acetylation of residues around position K373 is necessary, particularly for binding to low-affinity proapoptotic promoters such as BAX, in vitro and in vivo; the Results ('Acetylation of various sites differentially influences the interaction of p53 with downstream promoters') show p53Q373 and endogenously K373-acetylated p53 interacting better with the low-affinity proapoptotic promoters of BAX, PIG3 and p53AIP1, with coherent changes in Bax protein levels, i.e. activation. The paper's K373 cassette is defined as the triple mutant at positions 370/372/373 (Results, 'Opposing effects of K320 and K373 acetylation...'), so 'residues around K373' encompasses K372/K373 as the claim words it; the only softening is that the Discussion attributes activation to a combination of effects (intrinsic affinity, hyperphosphorylation, nuclear retention). (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“single molecule fluorescence studies in living cells show that acetylation of the CTD stabilizes p53 binding by increasing the residence time at cognate sites.74”
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Discussion > Role of disordered N- and C-terminal regions in p53 target site search
What the sources say
- Supportedcites [74] source
The Results section 'The increase in p53 residence time is due to acetylation of the p53-CTD' reports live-cell single-molecule tracking showing that Set8 knockdown (increasing K382 acetylation) and the acetylation-mimicking mutants K382Q and 6Q raise p53 bound fraction and average residence time on chromatin, while the non-acetylatable K382R mutant shows no modulation (p. 7-8, Fig. 4b-d). The concluding passage (Results) states that CTD acetylation at K382 is both necessary and sufficient to stabilize p53 binding, matching the claim's attribution. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“they are broadened in spectra of p53 due to slow tumbling of the TET domain within the full-length tetramer.59”
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Discussion > The C-terminal domains in the context of full-length p53
What the sources say
- Could not verifycites [59] sourceExperimental — accuracy not yet measured
Our full-text copy of Wright et al. (2016, Oncotarget) is a cell-biochemistry/in-vitro HAT study of HBZ repression of p53 acetylation; it contains no NMR spectroscopy, no TET-domain resonance assignments, and no statement about line broadening or slow tumbling of the p53 tetramer. Searches for 'NMR / cross-peak / broadened / chemical shift', 'TET domain / tetramer / tumbling', and 'p53 oligomerization / C-terminal domain structure' returned only the INTRODUCTION/DISCUSSION on p53 lysine acetylation (K370-K382, pp. INTRODUCTION and DISCUSSION), the In vitro HAT assay, GST pull-down, ChIP and qPCR methods, and reference-list entries (Refs 1-16, 48-61, 69-82) — none of which addresses the claimed spectral-broadening point. The copy is not truncated, so the absence is not a gap in our holdings, but nothing in it supports or contradicts the attribution. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
38 more claims · 3 with their cited sources checked
Create a free account to see all 72 claims and to verify the 37 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 10
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Results > The NLS and CTD are disordered in full-length p53
“the disordered NLS (residues 304-325)”
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Introduction
“nuclear localization signal (NLS, residues 316-325)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Results > The NLS and CTD are disordered in full-length p53
“CTD (residues 357-393) domains”
§ Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR > Introduction
“C-terminal regulatory domain (CTD, residues 364-393)”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
NMR View: A computer program for the visualization and analysis of NMR data
Johnson, B. A., & Blevins, R. A. (1994) · Journal of Biomolecular NMR · doi:10.1007/bf00404272 · Cited by 3,090
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Pervushin, K., Riek, R., Wider, G., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,445
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204
Wittekind, M., & Mueller, L. (1993) · Journal of Magnetic Resonance, Series B · doi:10.1006/jmrb.1993.1033 · Cited by 859
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Research works printed but not linked: 2
- Addison C., 1990, Oncogene, 5, 423
- Stürzbecher H. W., 1992, Oncogene, 7, 1513
Cited by
TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review)
Tornesello, M. L. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5448 · Cited by 120
Dynamics and interactions of intrinsically disordered proteins
Arai, M., Suetaka, S., & Ooka, K. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102734 · Cited by 39
How does p53 work? Regulation by the intrinsically disordered domains
Dyson, H. J., & Wright, P. E. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.10.009 · Cited by 29
Self-citationXu, B., Maimaitijiang, A., Nuerbiyamu, D., Su, Z., & Li, W. (2025) · Biomolecules · doi:10.3390/biom15081088 · Cited by 23
Distinguishing features of fold‐switching proteins
Chakravarty, D., Schafer, J. W., & Porter, L. L. (2023) · Protein Science · doi:10.1002/pro.4596 · Cited by 21
Metadata
- Authors
- Krois, A. S., Park, S., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E.
- Affiliations
- Scripps Research Institute (US)
- Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California92037, United Sates
- Corresponding author
- Wright, Peter E.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-11-16
- Volume
- 61
- Issue
- 23
- Pages
- 2709-2719
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- PMC
- PMC9788666
- OpenAlex
- W4309161821
- Semantic Scholar
- c045343c69d5b0d4a42c7254de45ebcf4ed77812
- Cited by
- 14
- References
- 74
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 2 · 2023: 4
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Licence
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA096865)
- National Institute of General Medical Sciences (GM075995, GM131693)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Physical Sciences › Chemistry › Spectroscopy › Advanced NMR Techniques and Applications
- Keywords
- p53, intrinsically disordered regions, C-terminal regulatory domain, tetramerization domain, nuclear localization signal, DNA binding, lysine acetylation, 15N labeling, protein-DNA interactions, tumor suppressor proteins
- MeSH terms
- DNA, Isotope Labeling, Protein Binding, Tumor Suppressor Protein p53, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.